Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Assessment of the efficacy and safety of tocilizumab in patients over 80 years old with giant cell arteritis ; volume:23 ; number:1 ; day:19 ; month:5 ; year:2021 ; pages:1-7 ; date:12.2021
Arthritis Research & Therapy ; 23, Heft 1 (19.5.2021), 1-7, 12.2021
- Creator
-
de Boysson, Hubert
Le Besnerais, Maelle
Blaison, Félix
Daumas, Aurélie
Jarrot, Pierre-André
Perrin, François
Tieulié, Nathalie
Maria, Alexandre
Duffau, Pierre
Gombert, Bruno
Samson, Maxime
Espitia, Olivier
Lambert, Marc
Mékinian, Arsène
Aouba, Achille
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-021-02529-4
- URN
-
urn:nbn:de:101:1-2021091806531988693943
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- de Boysson, Hubert
- Le Besnerais, Maelle
- Blaison, Félix
- Daumas, Aurélie
- Jarrot, Pierre-André
- Perrin, François
- Tieulié, Nathalie
- Maria, Alexandre
- Duffau, Pierre
- Gombert, Bruno
- Samson, Maxime
- Espitia, Olivier
- Lambert, Marc
- Mékinian, Arsène
- Aouba, Achille
- SpringerLink (Online service)
Other Objects (12)
Vision loss in patients with giant cell arteritis treated with tocilizumab
Tocilizumab for relapsing and remitting giant cell arteritis: a case series
Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study
Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data
PET/CT uncovers cranial giant cell arteritis
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres
The Diagnosis and Treatment of Giant Cell Arteritis
Calciphylaxis Mimicking Giant Cell Arteritis: A Case Report
Integrated safety in tocilizumab clinical trials
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Vision loss in patients with giant cell arteritis treated with tocilizumab
Tocilizumab for relapsing and remitting giant cell arteritis: a case series
Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study
Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data
PET/CT uncovers cranial giant cell arteritis
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres
The Diagnosis and Treatment of Giant Cell Arteritis
Calciphylaxis Mimicking Giant Cell Arteritis: A Case Report
Integrated safety in tocilizumab clinical trials
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
Vision loss in patients with giant cell arteritis treated with tocilizumab
Tocilizumab for relapsing and remitting giant cell arteritis: a case series
Tocilizumab-associated posterior reversible encephalopathy syndrome in giant-cell arteritis – case report
Intravenous tocilizumab for the treatment of giant cell arteritis: a phase Ib dose-ranging pharmacokinetic bridging study
Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims Data
PET/CT uncovers cranial giant cell arteritis
Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres
The Diagnosis and Treatment of Giant Cell Arteritis
Calciphylaxis Mimicking Giant Cell Arteritis: A Case Report
Integrated safety in tocilizumab clinical trials